Abstract
The major depressive disorder (MDD) affecting a large amount of population still has unknown neurobiological mechanisms and dissatisfactory treatment response.Given the urgently need for effective predictive markers for diagnosis and treatment, epigenetic studies of neuropsychiatric disorders including non-coding RNAs (ncRNAs) expand the research.Non-coding RNAs including microRNA, long noncoding RNA and circular RNA, may play important roles on neural differentiation, synaptic plasticity and central neurological reaction of stress during the course of antidepressant treatment.The current knowledge was summarized about posttranscriptional regulation of ncRNAs in major depression and discussed the potential biomarker value of ncRNAs for treatment evaluation in the context of individualized treatment. Key words: Non-coding RNA; Major depressive disorder; Antidepressant; Treatment
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
